CD4 T cells inhibit in vivo the CD8‐mediated immune response against murine colon carcinoma cells transduced with interleukin‐12 genes
Authors:
- Antonella StoppacciaroASAntonella Stoppacciaro
- Maddalena VaglianiMVMaddalena Vagliani
- Cecilia MelaniCMCecilia Melani
- Fabio SpreaficoFSFabio Spreafico
- Giorgio ParmianiGPGiorgio Parmiani
- Mario P. ColomboMCMario P. Colombo
- 1 January 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (1) , 137-146
Abstract
Retroviral‐mediated cytokine gene transfer into tumor cells is a highly effective way of inducing tumor inhibition and immunity. We analyzed the tumorigenicity of C‐26 murine colon carcinoma cells transduced with genes encoding the two subunits of murine interleukin‐12 (IL‐12) in a polycistronic retroviral vector and selected for resistance to G418 and for IL‐12 production (30–80 pg/ml). BALB/c mice injected s.c., i.v. and intrasplenically with C‐26/IL‐12 cells from three different IL‐12‐producing clones showed delayed tumor onset as compared with mice injected with control NeoR‐transduced or parental tumor cells. Although C‐26/IL‐12 tumor‐bearing mice eventually died of lung metastasis, their survival time was twice as long as that of mice injected with control cells. In experiments with mice selectively depleted of natural killer (NK) cells before tumor cell injection, the time of tumor onset and survival of mice injected with C‐26/IL‐12 s.c. and i.v., respectively, was reduced. CD8+ T cell depletion had no effect on latency or survival, whereas removal of CD4+ T cells led to C‐26/IL‐12 tumor regression in about 40% of mice. Histological and immunocytochemical characterization of leukocytes infiltrating C‐26/IL‐12 tumors showed only slight infiltration with few T cells in non‐depleted mice but abundant infiltration by CD8+ T cells and asialo‐GM1+ NK cells in tumors of mice depleted of CD4+ T cells. The lack of CD8+ T cell infiltration is not due to a CD4‐mediated suppression of their activation because irradiated C‐26/IL‐12 cells primed for the induction of a strong cytotoxic T lymphocyte response against C‐26 parental cells and induced CD8+ effector cells that protected against C‐26/IL‐12 in a Winn assay. Rather, the results suggest that, although C‐26/IL‐12 cells injected in vivo stimulate both NK and CD8+ T cells, tumor infiltration by the latter is inhibited by CD4+ T cells.Keywords
This publication has 34 references indexed in Scilit:
- Experimental and Clinical Studies of Cytokine Gene-Modified Tumor CellsHuman Gene Therapy, 1994
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.Journal of Experimental Medicine, 1993
- Interleukin‐12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cellsEuropean Journal of Immunology, 1993
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Recombinant interleukin 12 cures mice infected with Leishmania major.Journal of Experimental Medicine, 1993
- Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.Proceedings of the National Academy of Sciences, 1990
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.Journal of Experimental Medicine, 1989
- Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences, 1980
- Accurate Identification of Experimental Pulmonary Metastases2JNCI: Journal of the National Cancer Institute, 1966